Biosante Pharmaceuticals shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Biosante Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Biosante Pharmaceuticals held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Biosante Pharmaceuticals by Rhumbline Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $2.1M | 38k | 55.14 |
| 2023-09-30 | $2.3M | 40k | 58.06 |
| 2023-06-30 | $1.9M | 35k | 53.83 |
| 2023-03-31 | $1.3M | 34k | 39.72 |
| 2022-12-31 | $1.3M | 32k | 40.22 |
| 2022-09-30 | $986k | 31k | 32.14 |
| 2022-06-30 | $896k | 30k | 29.67 |
| 2022-03-31 | $728k | 26k | 28.09 |
| 2021-12-31 | $1.1M | 25k | 46.09 |
| 2021-09-30 | $1.0M | 31k | 32.83 |
| 2021-06-30 | $1.2M | 34k | 35.04 |
| 2021-03-31 | $1.3M | 35k | 36.15 |
| 2020-12-31 | $978k | 34k | 29.04 |
| 2020-09-30 | $859k | 30k | 28.22 |
| 2020-06-30 | $1.0M | 32k | 32.33 |
| 2020-03-31 | $1.3M | 32k | 40.73 |
| 2019-12-31 | $1.9M | 31k | 61.67 |
| 2019-09-30 | $2.1M | 29k | 72.87 |
| 2019-06-30 | $2.2M | 27k | 82.21 |
| 2019-03-31 | $1.7M | 24k | 70.56 |
| 2018-12-31 | $1.1M | 24k | 45.03 |
| 2018-09-30 | $1.2M | 21k | 56.53 |
| 2018-06-30 | $1.5M | 22k | 66.82 |
| 2018-03-31 | $1.2M | 21k | 58.24 |
| 2017-12-31 | $1.3M | 20k | 64.43 |
| 2017-09-30 | $891k | 17k | 52.47 |
| 2017-06-30 | $748k | 16k | 46.77 |
| 2017-03-31 | $796k | 16k | 49.52 |
| 2016-12-31 | $749k | 12k | 60.66 |
| 2016-09-30 | $734k | 11k | 66.37 |
| 2016-06-30 | $563k | 10k | 55.85 |
| 2016-03-31 | $333k | 9.9k | 33.68 |
| 2015-12-31 | $442k | 9.8k | 45.17 |
| 2015-09-30 | $360k | 9.1k | 39.49 |
| 2015-06-30 | $553k | 8.9k | 62.00 |
| 2015-03-31 | $557k | 8.9k | 62.51 |
| 2014-12-31 | $378k | 6.7k | 56.33 |